Meitav Investment House Ltd. purchased a new position in HCA Healthcare, Inc. (NYSE:HCA – Free Report) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 2,870 shares of the company’s stock, valued at approximately $1,166,000.
Other large investors have also bought and sold shares of the company. Oak Harvest Investment Services bought a new position in HCA Healthcare in the third quarter worth $2,875,000. Adams Diversified Equity Fund Inc. purchased a new position in shares of HCA Healthcare during the third quarter valued at approximately $12,396,000. Hedeker Wealth LLC grew its stake in shares of HCA Healthcare by 3.0% in the 3rd quarter. Hedeker Wealth LLC now owns 11,263 shares of the company’s stock worth $4,577,000 after buying an additional 325 shares during the last quarter. PBMares Wealth Management LLC bought a new stake in HCA Healthcare in the third quarter worth $222,000. Finally, Integrated Advisors Network LLC increased its holdings in shares of HCA Healthcare by 0.6% during the third quarter. Integrated Advisors Network LLC now owns 5,132 shares of the company’s stock valued at $2,086,000 after acquiring an additional 31 shares in the last quarter. 62.73% of the stock is owned by institutional investors.
HCA Healthcare Stock Down 0.5 %
Shares of HCA stock opened at $359.12 on Thursday. The company has a market capitalization of $94.06 billion, a price-to-earnings ratio of 18.00, a PEG ratio of 1.52 and a beta of 1.67. The company has a debt-to-equity ratio of 27.11, a current ratio of 1.06 and a quick ratio of 0.94. The company’s fifty day moving average price is $394.11 and its 200-day moving average price is $353.54. HCA Healthcare, Inc. has a one year low of $223.73 and a one year high of $417.14.
HCA Healthcare Dividend Announcement
Analyst Ratings Changes
Several research analysts have issued reports on HCA shares. Barclays lifted their target price on shares of HCA Healthcare from $376.00 to $396.00 and gave the stock an “overweight” rating in a report on Wednesday, July 24th. Cantor Fitzgerald reiterated an “overweight” rating and set a $392.00 target price on shares of HCA Healthcare in a research note on Tuesday, October 1st. Wells Fargo & Company upped their price target on HCA Healthcare from $365.00 to $395.00 and gave the company an “equal weight” rating in a report on Tuesday, October 22nd. KeyCorp lowered their target price on shares of HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating on the stock in a research note on Monday. Finally, Truist Financial increased their price objective on shares of HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a research report on Monday, August 19th. Five analysts have rated the stock with a hold rating, thirteen have issued a buy rating and three have issued a strong buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $379.11.
Insider Buying and Selling
In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of HCA Healthcare stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the sale, the executive vice president now directly owns 29,678 shares in the company, valued at approximately $11,438,494.76. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. 1.60% of the stock is owned by insiders.
HCA Healthcare Profile
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Read More
- Five stocks we like better than HCA Healthcare
- Bank Stocks – Best Bank Stocks to Invest In
- Zillow Stock’s Bull Case: Why This Recent Sell-Off Could Be a Buy
- What Are Growth Stocks and Investing in Them
- IonQ’s Quantum Surge: Ride the Wave or Cash Out?
- How to Calculate Stock Profit
- Caterpillar Stock: Market Points to a Buying Opportunity
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.